Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Endo Pharmaceuticals and Orion Corporation Begin Novel R & D Collaboration

January 27, 2011 10:35 pm | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., Jan. 28, 2011 /- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that it has entered into a collaboration agreement with European-based Orion Corporation for the discovery, development and commercialization of assets in Oncology. The formation of this R&D...

TOPICS:

Decoding Pneumonia's Defenses

January 27, 2011 7:36 pm | by Massachusetts Institute of Technology | News | Comments

Researchers sequence more than 200 strains of the bug and find a catalog of ways they evade drugs and vaccines.

3 insurers agree to delay Calif rate increases(2)

January 27, 2011 4:46 pm | by DON THOMPSON - Associated Press - Associated Press | News | Comments

Customers of three California health insurers will get some breathing room after the companies agreed Thursday to delay rate increases for 60 days, isolating Blue Shield of California as the lone holdout.Anthem Blue Cross, Aetna and PacifiCare agreed to the delay to give the state Department of...

Advertisement

3 insurers agree to delay Calif rate increases

January 27, 2011 4:45 pm | News | Comments

Customers of three California health insurers will get some breathing room after the companies agreed Thursday to delay rate increases for 60 days, isolating Blue Shield of California as the lone holdout.Anthem Blue Cross, Aetna and PacifiCare agreed to the delay to give the state Department of...

Oklahoma to continue using sedative in executions

January 27, 2011 1:45 pm | by TIM TALLEY - Associated Press - Associated Press | News | Comments

Oklahoma prison officials will continue using a sedative as part of the state's three-drug lethal injection protocol despite objections from the drug's manufacturer, a spokesman for the state Department of Corrections said Thursday.Denmark-based Lundbeck, Inc., producer of the drug...

US state to continue using sedative in executions

January 27, 2011 1:45 pm | by TIM TALLEY - Associated Press - Associated Press | News | Comments

Oklahoma prison officials will continue using a sedative as part of the state's three-drug lethal injection protocol despite objections from the drug's manufacturer, a spokesman for the state Department of Corrections said Thursday.Denmark-based Lundbeck, Inc., producer of the drug...

Accuray Announces Results for Second Quarter of Fiscal 2011

January 27, 2011 1:36 pm | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Jan. 27, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today financial results for the second quarter of fiscal year 2011, ended December 31, 2010. For the second quarter of fiscal 2011, Accuray reported total...

TOPICS:

Surgical Information Systems Completes IHE North American Connectathon

January 27, 2011 1:36 pm | by Bio-Medicine.Org | News | Comments

ATLANTA, Jan. 27, 2011 /- Surgical Information Systems ("SIS"), a leader in perioperative information systems, announced today that it has successfully completed the healthcare industry's week-long interoperability testing event, Integrating the Healthcare Enterprise (IHE) Connectathon....

TOPICS:
Advertisement

Young Innovations, Inc. Provides 4th Quarter Conference Call Details

January 27, 2011 1:34 pm | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Jan. 27, 2011 /- Young Innovations, Inc. (Nasdaq: YDNT ) today announced that it will broadcast its fourth quarter earnings results with a live and on-demand web cast conference call on Thursday, February 3, 2011 at 11:00 a.m. Central Time. A live audio broadcast of the call...

TOPICS:

Sanofi-aventis Reports Top-line Results from Phase III Study with Iniparib (BSI-201) in Metastatic Triple-Negative Breast Cancer

January 27, 2011 1:33 pm | by Bio-Medicine.Org | News | Comments

BRIDGEWATER, N.J., Jan. 27, 2011 /- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) and its subsidiary, BiPar Sciences, today announced that a randomized Phase III trial evaluating iniparib* (BSI-201) in patients with metastatic triple-negative breast cancer (mTNBC) did not meet the...

TOPICS:

FDA warns Baxter about its 2 facilities in PRico

January 27, 2011 12:45 pm | by The Associated Press | News | Comments

Baxter International Inc., a medical products and services company, is addressing concerns cited in a warning letter from the U.S. Food and Drug Administration regarding two of its facilities in Puerto Rico, the company's spokeswoman said Thursday.The letter focuses on good manufacturing...

Discovery could lead to new therapies for asthma, COPD

January 27, 2011 12:33 pm | by EurekAlert | News | Comments

(University of Texas Medical Branch at Galveston) Researchers have proved that a single "master switch" enzyme, known as aldose reductase, is key in producing excess mucous that clogs the airways of people with asthma and chronic obstructive pulmonary disease.

TOPICS:

SiTime introduces first MEMS based programmable clock generator with LVCMOS and differential outputs

January 27, 2011 11:33 am | by I-Micronews | News | Comments

Unique SiT9105 expands clock generator portfolio and offers up to 66% board area reduction.

Researchers uncover link to increased atherosclerosis risk in lupus patients

January 27, 2011 10:33 am | by EurekAlert | News | Comments

(Wiley-Blackwell) Researchers in China have demonstrated interferon-alpha (IFN-a) is associated with increased risk of atherosclerosis in patients with systemic lupus erythematosus. For the first time, IFN-a priming was shown to promote lipid uptake and foam cell formation -- a...

TOPICS:

Vets to Provide Free Dog Heart Checks in West Palm Beach

January 27, 2011 9:32 am | by Bio-Medicine.Org | News | Comments

WEST PALM BEACH, Fla., Jan. 27, 2011 /- The Mobile Dog Heart Health Tour is heading to West Palm Beach for an afternoon of free heart health examinations at Dreher Dog Park. From 1 to 5 p.m. on Saturday, January 29, certified veterinary cardiologists will perform on-site heart screenings...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading